MXPA01011955A - Aminoacidos policiclicos, fusionados, como agentes farmaceuticos. - Google Patents
Aminoacidos policiclicos, fusionados, como agentes farmaceuticos.Info
- Publication number
- MXPA01011955A MXPA01011955A MXPA01011955A MXPA01011955A MXPA01011955A MX PA01011955 A MXPA01011955 A MX PA01011955A MX PA01011955 A MXPA01011955 A MX PA01011955A MX PA01011955 A MXPA01011955 A MX PA01011955A MX PA01011955 A MXPA01011955 A MX PA01011955A
- Authority
- MX
- Mexico
- Prior art keywords
- amino acids
- pharmaceutical agents
- fused polycyclic
- polycyclic amino
- fused
- Prior art date
Links
- 239000008177 pharmaceutical agent Substances 0.000 title 1
- -1 polycyclic amino acids Chemical class 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/14—Benz[f]indenes; Hydrogenated benz[f]indenes
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13610099P | 1999-05-26 | 1999-05-26 | |
| PCT/GB2000/001819 WO2000073259A1 (en) | 1999-05-26 | 2000-05-12 | Fused polycyclic amino acids as pharmaceutical agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA01011955A true MXPA01011955A (es) | 2003-09-04 |
Family
ID=22471297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA01011955A MXPA01011955A (es) | 1999-05-26 | 2000-05-12 | Aminoacidos policiclicos, fusionados, como agentes farmaceuticos. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1180094B1 (enExample) |
| JP (1) | JP2003500466A (enExample) |
| AT (1) | ATE272048T1 (enExample) |
| AU (1) | AU4770400A (enExample) |
| BR (1) | BR0010961A (enExample) |
| CA (1) | CA2373210A1 (enExample) |
| DE (1) | DE60012508T2 (enExample) |
| DK (1) | DK1180094T3 (enExample) |
| ES (1) | ES2228524T3 (enExample) |
| HK (1) | HK1040237B (enExample) |
| MX (1) | MXPA01011955A (enExample) |
| PT (1) | PT1180094E (enExample) |
| WO (1) | WO2000073259A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0313432A (pt) * | 2002-08-15 | 2005-07-12 | Pfizer | Uso terapêutico de aminoácidos bicìclicos ou tricìclicos fundidos |
| EP1820502A1 (en) | 2006-02-10 | 2007-08-22 | Laboratorios Del Dr. Esteve, S.A. | Active substance combination comprising azolylcarbinol compounds |
| EP2116539A1 (en) | 2008-04-25 | 2009-11-11 | Laboratorios Del. Dr. Esteve, S.A. | 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof |
| EP2353591A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof |
| EP2353598A1 (en) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for use in the prevention and/or treatment of postoperative pain |
| EP2388005A1 (en) | 2010-05-21 | 2011-11-23 | Laboratorios Del. Dr. Esteve, S.A. | Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
| EP2415471A1 (en) | 2010-08-03 | 2012-02-08 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in opioid-induced hyperalgesia |
| EP2524694A1 (en) | 2011-05-19 | 2012-11-21 | Laboratorios Del. Dr. Esteve, S.A. | Use of sigma ligands in diabetes type-2 associated pain |
| SG11201604480PA (en) | 2013-12-17 | 2016-07-28 | Esteve Labor Dr | SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS |
| MX2016007286A (es) | 2013-12-17 | 2016-08-04 | Esteve Labor Dr | Combinaciones de gabapentinoides y ligandos de receptores sigma. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI942059L (fi) * | 1991-11-05 | 1994-07-04 | Smithkline Beecham Corp | Endoteliinireseptoreiden antagonisteja |
| NZ334898A (en) * | 1996-10-23 | 2000-09-29 | Warner Lambert Co | Substituted gamma aminobutyric acids as pharamceutical agents |
| ATE323067T1 (de) * | 1997-10-27 | 2006-04-15 | Warner Lambert Co | Zyklische aminosäuren und deren derivate als arzneimittel |
-
2000
- 2000-05-12 JP JP2000621326A patent/JP2003500466A/ja active Pending
- 2000-05-12 MX MXPA01011955A patent/MXPA01011955A/es active IP Right Grant
- 2000-05-12 CA CA002373210A patent/CA2373210A1/en not_active Abandoned
- 2000-05-12 PT PT00929701T patent/PT1180094E/pt unknown
- 2000-05-12 AT AT00929701T patent/ATE272048T1/de not_active IP Right Cessation
- 2000-05-12 WO PCT/GB2000/001819 patent/WO2000073259A1/en not_active Ceased
- 2000-05-12 ES ES00929701T patent/ES2228524T3/es not_active Expired - Lifetime
- 2000-05-12 EP EP00929701A patent/EP1180094B1/en not_active Expired - Lifetime
- 2000-05-12 HK HK02101978.2A patent/HK1040237B/en not_active IP Right Cessation
- 2000-05-12 BR BR0010961-4A patent/BR0010961A/pt not_active Application Discontinuation
- 2000-05-12 DE DE60012508T patent/DE60012508T2/de not_active Expired - Fee Related
- 2000-05-12 DK DK00929701T patent/DK1180094T3/da active
- 2000-05-12 AU AU47704/00A patent/AU4770400A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1180094B1 (en) | 2004-07-28 |
| HK1040237B (en) | 2004-12-31 |
| DE60012508D1 (de) | 2004-09-02 |
| ES2228524T3 (es) | 2005-04-16 |
| EP1180094A1 (en) | 2002-02-20 |
| WO2000073259A1 (en) | 2000-12-07 |
| JP2003500466A (ja) | 2003-01-07 |
| PT1180094E (pt) | 2004-10-29 |
| DE60012508T2 (de) | 2005-06-23 |
| DK1180094T3 (da) | 2004-11-01 |
| AU4770400A (en) | 2000-12-18 |
| HK1040237A1 (en) | 2002-05-31 |
| CA2373210A1 (en) | 2000-12-07 |
| ATE272048T1 (de) | 2004-08-15 |
| BR0010961A (pt) | 2002-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9914486D0 (en) | Medicaments | |
| PL344599A1 (en) | Novel cyclosporins | |
| SE9904505D0 (sv) | Novel compounds | |
| IL145429A0 (en) | N-cyanomethyl amides, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP9902136A3 (en) | Novel substituted cyclic amino acid derivatives use as pharmaceutical agents | |
| GB0018828D0 (en) | Alkyl Amino Acid Derivatives useful as pharmaceutical agents | |
| RU95101048A (ru) | Производные пролинамида, фармкомпозиция на их основе | |
| IL133623A0 (en) | Antithrombotic agents | |
| IL133627A0 (en) | Antithrombotic agents | |
| BG106586A (en) | Pyrazolopyramidines as therapeutic agents | |
| LU91145I2 (fr) | FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX). | |
| MXPA02007942A (es) | Derivados de pirrolopirimidinona, procesos de preparacion y uso. | |
| GB0109122D0 (en) | Novel compounds | |
| MX9706605A (es) | Derivados de indol como antagonistas de los aminoacidos exitadores. | |
| AU4770400A (en) | Fused polycyclic amino acids as pharmaceutical agents | |
| EP1019047A4 (en) | ANTITHROMBOTIC AGENTS | |
| TW252979B (enExample) | ||
| DE69104220D1 (de) | Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten. | |
| AU7470098A (en) | Antithrombotic agents | |
| SE9800865D0 (sv) | New Process | |
| IL134194A0 (en) | Streptogramines, their preparation and compositions containing them | |
| MXPA03007309A (es) | Derivados de amina sustituidos por tiofeno como inhibidores glyt-1. | |
| SE9901340D0 (sv) | Novel process | |
| AU1434201A (en) | Antithrombotic agents | |
| EP0980366A4 (en) | ANTITHROMOSIS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Change of company name or juridical status | ||
| FG | Grant or registration |